6-65295886-C-T

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_001142800.2(EYS):​c.2000G>A​(p.Arg667His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000285 in 1,547,622 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R667C) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00064 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00025 ( 0 hom. )

Consequence

EYS
NM_001142800.2 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts P:1U:8

Conservation

PhyloP100: 0.999

Publications

5 publications found
Variant links:
Genes affected
EYS (HGNC:21555): (eyes shut homolog) The product of this gene contains multiple epidermal growth factor (EGF)-like and LamG domains. The protein is expressed in the photoreceptor layer of the retina, and the gene is mutated in autosomal recessive retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
EYS Gene-Disease associations (from GenCC):
  • EYS-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinitis pigmentosa
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • retinitis pigmentosa 25
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008051574).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EYSNM_001142800.2 linkc.2000G>A p.Arg667His missense_variant Exon 12 of 43 ENST00000503581.6 NP_001136272.1 Q5T1H1-1
EYSNM_001292009.2 linkc.2000G>A p.Arg667His missense_variant Exon 12 of 44 NP_001278938.1 Q5T1H1-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EYSENST00000503581.6 linkc.2000G>A p.Arg667His missense_variant Exon 12 of 43 5 NM_001142800.2 ENSP00000424243.1 Q5T1H1-1
EYSENST00000370621.7 linkc.2000G>A p.Arg667His missense_variant Exon 12 of 44 1 ENSP00000359655.3 Q5T1H1-3
EYSENST00000370615.3 linkn.438G>A non_coding_transcript_exon_variant Exon 2 of 2 3
EYSENST00000447127.1 linkn.456G>A non_coding_transcript_exon_variant Exon 3 of 3 4

Frequencies

GnomAD3 genomes
AF:
0.000640
AC:
97
AN:
151662
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00172
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000592
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000221
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000272
AC:
42
AN:
154228
AF XY:
0.000282
show subpopulations
Gnomad AFR exome
AF:
0.00139
Gnomad AMR exome
AF:
0.000409
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000236
Gnomad OTH exome
AF:
0.00162
GnomAD4 exome
AF:
0.000246
AC:
344
AN:
1395852
Hom.:
0
Cov.:
38
AF XY:
0.000250
AC XY:
172
AN XY:
688146
show subpopulations
African (AFR)
AF:
0.00108
AC:
34
AN:
31536
American (AMR)
AF:
0.000732
AC:
26
AN:
35536
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25106
East Asian (EAS)
AF:
0.000197
AC:
7
AN:
35582
South Asian (SAS)
AF:
0.0000128
AC:
1
AN:
77974
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49210
Middle Eastern (MID)
AF:
0.00123
AC:
7
AN:
5686
European-Non Finnish (NFE)
AF:
0.000224
AC:
241
AN:
1077344
Other (OTH)
AF:
0.000484
AC:
28
AN:
57878
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
17
34
50
67
84
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000639
AC:
97
AN:
151770
Hom.:
0
Cov.:
33
AF XY:
0.000647
AC XY:
48
AN XY:
74172
show subpopulations
African (AFR)
AF:
0.00171
AC:
71
AN:
41452
American (AMR)
AF:
0.000591
AC:
9
AN:
15224
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5162
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4808
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10520
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000221
AC:
15
AN:
67828
Other (OTH)
AF:
0.00
AC:
0
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000505
Hom.:
1
Bravo
AF:
0.000691
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ExAC
AF:
0.000123
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Retinitis pigmentosa Pathogenic:1Uncertain:3
Jan 01, 2015
NIHR Bioresource Rare Diseases, University of Cambridge
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:research

- -

Apr 01, 2018
Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:research

- -

Jan 06, 2020
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

not provided Uncertain:2
Sep 27, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 667 of the EYS protein (p.Arg667His). This variant is present in population databases (rs549456693, gnomAD 0.2%). This missense change has been observed in individual(s) with retinitis pigmentosa (PMID: 28041643, 30718709, 31054281). ClinVar contains an entry for this variant (Variation ID: 438193). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Jan 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

EYS: PM2, BP4 -

Retinitis pigmentosa 25 Uncertain:2
May 26, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 24, 2017
Counsyl
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -

Retinal dystrophy Uncertain:1
Dec 15, 2018
Blueprint Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
20
DANN
Benign
0.95
DEOGEN2
Benign
0.055
.;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.17
N
LIST_S2
Benign
0.33
T;T
M_CAP
Uncertain
0.12
D
MetaRNN
Benign
0.0081
T;T
MetaSVM
Benign
-0.87
T
MutationAssessor
Benign
0.34
N;N
PhyloP100
1.0
PrimateAI
Benign
0.29
T
PROVEAN
Benign
0.35
N;N
REVEL
Benign
0.22
Sift
Uncertain
0.0070
D;D
Sift4G
Uncertain
0.049
D;D
Polyphen
0.0010
B;.
Vest4
0.12
MVP
0.20
MPC
0.0095
ClinPred
0.014
T
GERP RS
2.3
Varity_R
0.041
gMVP
0.78
Mutation Taster
=12/88
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs549456693; hg19: chr6-66005779; COSMIC: COSV65458786; API